Search - Leibniz Institute for Prevention Research and Epidemiology

211. [BIPS Project] Utilization of preventive services and socio-economic status in Germany exemplified by HPV vaccination (HPV-SES)

URL: /en/research/projects/detail-view.html?projID=1080&cHash=4682a962c0a95237b6f897bd8aad7fd6
Date: 29-08-23

In Germany, vaccination against Human papilloma viruses (HPV) is recommended by the Standing Committee on Vaccination (STIKO) for all girls and boys aged 9 to 14. They should preferably be concluded…

212. [BIPS Project] Utilization of drugs containing testosterone in Germany

URL: /en/research/projects/detail-view.html?projID=1025&cHash=fd853bf140f5788a48da1161e9e3dde2
Date: 01-03-23

Drugs containing testosterone are indicated in the treatment of testosterone deficiency caused by a malfunction of the testes, for the treatment of a delayed onset of puberty in boys as well as to…

213. [BIPS Project] Use of routine data for pharmacovigilance in Germany: Method development and initial applications

URL: /en/research/projects/detail-view.html?projID=682&cHash=0c0a196b94f82e6d713e27ec56faed29
Date: 01-01-17

Adverse drug events are one of the most frequent causes of death. There are market withdrawals for pharmaceutical products from time to time, because severe side effects were not recognized before…

214. [BIPS Project] Use of population databases with double sampling for choice-based sample surveys and time-to-event data (Project in the Priority Programme on Survey Methodology)

URL: /en/research/projects/detail-view.html?projID=347&cHash=42a741c6afca8706155dfb5d322c6c46
Date: 01-03-10

Two-phase or double sampling methods were developed for studies with missing or imprecise covariate information. These methods are typically applied, if information on the event and crude information…

215. [BIPS Project] Use of parenteral Iron-(III)-products in Germany

URL: /en/research/projects/detail-view.html?projID=895&cHash=3d67e81637e9b2340576a04b68cb19b4
Date: 01-12-20

Parenteral iron (III) preparations are used since the 1950s for the treatment of iron deficiency, if oral iron preparations are not effective or cannot be used. Due to safety concerns due to…

216. [BIPS Project] Use of opioid-containing drugs in Germany

URL: /en/research/projects/detail-view.html?projID=976&cHash=948b1495e09b9bf3abcf294ef306f1d7
Date: 01-01-22

Opioids are among the most effective drugs to treat moderate to severe pain. Considering the WHO analgesic ‘ladder’, their use in tumor-related pain, acute pain, and palliative care is…

217. [BIPS Project] Use of combined oral contraceptives and risk of venous thromboembolism

URL: /en/research/projects/detail-view.html?projID=796&cHash=6cf96f97818e0f99ec23abef85283979
Date: 01-02-19

Combined hormonal contraceptives (CHC) are the most widely used method of birth control in Germany. In 2018, an estimated 210 million daily doses covered by statutory health insurance providers were…

218. [BIPS Project] Use of carbimazole, thiamazole and propylthiouracil during pregnancy in Germany

URL: /en/research/projects/detail-view.html?projID=894&cHash=360cf7a4e4f0188d032db6703f0c1a62
Date: 01-12-20

The treatment of Graves' disease in girls and women of childbearing age is particularly challenging due to the potential occurrence of pregnancy. Failure to treat the hyperthyroidism associated with…

219. [BIPS Project] Two-phase methodology for the combined analysis of secondary data sources

URL: /en/research/projects/detail-view.html?projID=466&cHash=a95d64bf728dce406857c82139a34453
Date: 11-05-12

Administrative data of statutory health insurances are a valuable data source for pharmacoepidemiological studies and health services research. The validity of studies based on these data might be…

220. [BIPS Project] The use of MS-medications in girls and women of childbearing age and during pregnancy in Germany

URL: /en/research/projects/detail-view.html?projID=975&cHash=b4ae4cbff4db2a01eb8b0b480a4a4089
Date: 01-01-22

Multiple sclerosis (MS) is the most common central nervous autoimmune disease in Germany with a typical onset in early adulthood between the ages of 20 and 40. Women are about three times more likely…